{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:00:33Z","timestamp":1794470433974,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"crossref","award":["#2019\/17769-1"],"award-info":[{"award-number":["#2019\/17769-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"crossref","award":["# 30699-2014"],"award-info":[{"award-number":["# 30699-2014"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Coordination of Superior Level Staff Improvement","award":["#001"],"award-info":[{"award-number":["#001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study evaluated the peri-implant tissues under normal conditions and under the influence of experimental peri-implantitis (EPI) in osseointegrated implants installed in the maxillae of rats treated with oncologic dosage of zoledronate. Twenty-eight senescent female rats underwent the extraction of the upper incisor and placement of a titanium dental implant (DI). After eight weeks was installated a transmucosal healing screw on DI. After nine weeks, the following groups were formed: VEH, ZOL, VEH-EPI and ZOL-EPI. From the 9th until the 19th, VEH and VEH-EPI groups received vehicle and ZOL and ZOL-EPI groups received zoledronate. At the 14th week, a cotton ligature was installed around the DI in VEH-EPI and ZOL-EPI groups to induce the EPI. At the 19th week, euthanasia was performed, and the maxillae were processed so that at the implanted sites were analyzed: histological aspects and the percentage of total bone tissue (PTBT) and non-vital bone tissue (PNVBT), along with TNF\u03b1, IL-1\u03b2, VEGF, OCN and TRAP immunolabeling. ZOL group presented mild persistent peri-implant inflammation, higher PNVBT and TNF\u03b1 and IL-1\u03b2 immunolabeling, but lower for VEGF, OCN and TRAP in comparison with VEH group. ZOL-EPI group exhibited exuberant peri-implant inflammation, higher PNVBT and TNF\u03b1 and IL-1\u03b2 immunolabeling when compared with ZOL and VEH-EPI groups. Zoledronate disrupted peri-implant environment, causing mild persistent inflammation and increasing the quantity of non-vital bone tissue. Besides, associated with the EPI there were an exacerbated inflammation and even greater increase in the quantity of non-vital bone around the DI, which makes this condition a risk factor for medication-related osteonecrosis of the jaws.<\/jats:p>","DOI":"10.1038\/s41598-023-49647-4","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T13:03:17Z","timestamp":1704459797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Peri-implantitis increases the risk of medication-related osteonecrosis of the jaws associated with osseointegrated implants in rats treated with zoledronate"],"prefix":"10.1038","volume":"14","author":[{"given":"Eduardo","family":"Quint\u00e3o Manhanini Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan","family":"Felipe Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius","family":"Franz\u00e3o Ganzaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"de Oliveira Alvarenga Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza Akemi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e1udio Aparecido","family":"Casatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Tavares \u00c2ngelo Cintra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rog\u00e9rio","family":"Leone Buchaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo","family":"Mardegan Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdir","family":"Gouveia Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia Helena","family":"Theodoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edilson","family":"Ervolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"49647_CR1","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","volume":"80","author":"SL Ruggiero","year":"2022","unstructured":"Ruggiero, S. L. et al. American Association of Oral and Maxillofacial Surgeons\u2019 position paper on medication-related osteonecrosis of the jaws-2022 update. J. Oral Maxillofac. Surg. 80, 920\u2013943 (2022).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"49647_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","volume":"27","author":"T Aghaloo","year":"2015","unstructured":"Aghaloo, T., Hazboun, R. & Tetradis, S. Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac. Surg. Clin. North Am. 27, 489\u2013496 (2015).","journal-title":"Oral Maxillofac. Surg. Clin. North Am."},{"key":"49647_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41368-020-00093-2","volume":"12","author":"L He","year":"2020","unstructured":"He, L., Sun, X., Liu, Z., Qiu, Y. & Niu, Y. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int. J. Oral. Sci. 12, 30 (2020).","journal-title":"Int. J. Oral. Sci."},{"key":"49647_CR4","doi-asserted-by":"publisher","first-page":"23500","DOI":"10.1002\/dvg.23500","volume":"60","author":"S Kuroshima","year":"2022","unstructured":"Kuroshima, S., Al-Omari, F. A., Sasaki, M. & Sawase, T. Medication-related osteonecrosis of the jaw: A literature review and update. Genesis 60, 23500 (2022).","journal-title":"Genesis"},{"key":"49647_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-020-0088-1","author":"JT Wan","year":"2020","unstructured":"Wan, J. T., Sheeley, D. M., Somerman, M. J. & Lee, J. S. Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res. https:\/\/doi.org\/10.1038\/s41413-020-0088-1 (2020).","journal-title":"Bone Res."},{"key":"49647_CR6","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1007\/s00784-021-04261-4","volume":"26","author":"A Wick","year":"2022","unstructured":"Wick, A. et al. Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab. Clin. Oral Investig. 26, 2839\u20132852 (2022).","journal-title":"Clin. Oral Investig."},{"key":"49647_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/clr.12088","volume":"25","author":"TG Kwon","year":"2014","unstructured":"Kwon, T. G. et al. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin. Oral Implants Res. 25, 632\u2013640 (2014).","journal-title":"Clin. Oral Implants Res."},{"key":"49647_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/SCS.0000000000002564","volume":"27","author":"I Giovannacci","year":"2016","unstructured":"Giovannacci, I. et al. Medication-related osteonecrosis of the jaw around dental implants: Implant surgery-triggered or implant presence-triggered osteonecrosis?. J. Craniofac. Surg. 27, 697\u2013701 (2016).","journal-title":"J. Craniofac. Surg."},{"key":"49647_CR9","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/j.1600-0501.2009.01801.x","volume":"20","author":"T Shirota","year":"2009","unstructured":"Shirota, T. et al. Bisphosphonate-related osteonecrosis of the jaw around dental implants in the maxilla: Report of a case. Clin. Oral Implants Res. 20, 1402\u20131408 (2009).","journal-title":"Clin. Oral Implants Res."},{"key":"49647_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.joms.2009.09.037","volume":"68","author":"A Goss","year":"2010","unstructured":"Goss, A., Bartold, M., Sambrook, P. & Hawker, P. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: A South Australian case series. J. Oral Maxillofac. Surg. 68, 337\u2013343 (2010).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"49647_CR11","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.joms.2009.09.017","volume":"68","author":"TS Lazarovici","year":"2010","unstructured":"Lazarovici, T. S. et al. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J. Oral Maxillofac. Surg. 68, 790\u2013796 (2010).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"49647_CR12","first-page":"568246","volume":"2011","author":"L Junquera","year":"2011","unstructured":"Junquera, L., Gallego, L. & Pelaz, A. Multiple myeloma and bisphosphonate-related osteonecrosis of the mandible associated with dental implants. Case Rep. Dent. 2011, 568246 (2011).","journal-title":"Case Rep. Dent."},{"key":"49647_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.bjoms.2013.06.011","volume":"51","author":"JL L\u00f3pez-Cedr\u00fan","year":"2013","unstructured":"L\u00f3pez-Cedr\u00fan, J. L. et al. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: A case series. Br. J. Oral Maxillofac. Surg. 51, 874\u2013879 (2013).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"issue":"1937","key":"49647_CR14","first-page":"e1","volume":"72","author":"D Holzinger","year":"2014","unstructured":"Holzinger, D. et al. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J. Oral Maxillofac. Surg. 72(1937), e1-1937.e19378 (2014).","journal-title":"J. Oral Maxillofac. Surg."},{"key":"49647_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.12659\/AJCR.894162","volume":"16","author":"G Favia","year":"2015","unstructured":"Favia, G. et al. Metastatic breast cancer in medication-related osteonecrosis around mandibular implants. Am. J. Case Rep. 16, 621\u2013626 (2015).","journal-title":"Am. J. Case Rep."},{"key":"49647_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10266-015-0207-4","volume":"104","author":"A Matsuo","year":"2016","unstructured":"Matsuo, A. et al. Evaluation of dental implants as a risk factor for the development of bisphosphonate-related osteonecrosis of the jaw in breast cancer patients. Odontology 104, 363\u2013371 (2016).","journal-title":"Odontology"},{"key":"49647_CR17","doi-asserted-by":"publisher","first-page":"8093293","DOI":"10.1155\/2020\/8093293","volume":"2020","author":"F Bennardo","year":"2020","unstructured":"Bennardo, F., Buffone, C., Muraca, D., Antonelli, A. & Giudice, A. Medication-related osteonecrosis of the jaw with spontaneous hemimaxilla exfoliation: Report of a case in metastatic renal cancer patient under multidrug therapy. Case Rep. Med. 2020, 8093293 (2020).","journal-title":"Case Rep. Med."},{"key":"49647_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jormas.2019.04.012","volume":"121","author":"MF Escobedo","year":"2020","unstructured":"Escobedo, M. F. et al. Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review. J. Stomatol. Oral Maxillofac. Surg. 121, 40\u201348 (2020).","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"49647_CR19","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41432-021-0196-9","volume":"22","author":"B Owen","year":"2021","unstructured":"Owen, B. & Bradley, H. Is it safe to place implants in patients at risk of MRONJ?. Evid. Based Dent. 22, 108\u2013109 (2021).","journal-title":"Evid. Based Dent."},{"key":"49647_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1563\/aaid-joi-D-19-00351","volume":"47","author":"J Sher","year":"2021","unstructured":"Sher, J., Kirkham-Ali, K., Luo, J. D., Miller, C. & Sharma, D. Dental implant placement in patients with a history of medications related to osteonecrosis of the jaws: A systematic review. J. Oral Implantol. 47, 249\u2013268 (2021).","journal-title":"J. Oral Implantol."},{"key":"49647_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.jcms.2016.09.018","volume":"44","author":"M Troeltzsch","year":"2016","unstructured":"Troeltzsch, M. et al. Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?. J. Craniomaxillofac. Surg. 44, 1945\u20131951 (2016).","journal-title":"J. Craniomaxillofac. Surg."},{"key":"49647_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.bjoms.2020.03.022","volume":"58","author":"S Pichardo","year":"2020","unstructured":"Pichardo, S., Van der Hee, J. G., Fiocco, M., Appelman-Dijkstra, N. M. & Van Merkesteyn, J. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ). Br. J. Oral Maxillofac. Surg. 58, 771\u2013776 (2020).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"49647_CR23","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1563\/aaid-joi-D-19-00385","volume":"47","author":"K Seki","year":"2021","unstructured":"Seki, K., Namaki, S., Kamimoto, A. & Hagiwara, Y. Medication-related osteonecrosis of the jaw subsequent to peri-implantitis: A case report and literature review. J. Oral Implantol. 47, 502\u2013510 (2021).","journal-title":"J. Oral Implantol."},{"key":"49647_CR24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1111\/odi.13873","volume":"28","author":"A Tempesta","year":"2021","unstructured":"Tempesta, A. et al. Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope. Oral Dis. 28, 1603\u20131609 (2021).","journal-title":"Oral Dis."},{"key":"49647_CR25","first-page":"S246","volume":"45","author":"F Schwarz","year":"2018","unstructured":"Schwarz, F., Derks, J., Monje, A. & Wang, H. L. Peri-implantitis. J. Periodontol. 45, S246\u2013S266 (2018).","journal-title":"J. Periodontol."},{"key":"49647_CR26","first-page":"e8","volume":"26","author":"F Sgolastra","year":"2015","unstructured":"Sgolastra, F., Petrucci, A., Severino, M., Gatto, R. & Monaco, A. Periodontitis, implant loss and peri-implantitis: A meta-analysis. Clin. Oral Implants Res. 26, e8\u2013e16 (2015).","journal-title":"Clin. Oral Implants Res."},{"issue":"79","key":"49647_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/prd.12240","volume":"2000","author":"NP Lang","year":"2019","unstructured":"Lang, N. P., Salvi, G. E. & Sculean, A. Nonsurgical therapy for teeth and implants- when and why?. Periodontology 2000(79), 15\u201321 (2019).","journal-title":"Periodontology"},{"key":"49647_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/clr.13684","volume":"32","author":"M Romandini","year":"2021","unstructured":"Romandini, M. et al. Prevalence and risk\/protective indicators of peri-implant diseases: A university-representative cross-sectional study. Clin. Oral Implants Res. 32, 112\u2013122 (2021).","journal-title":"Clin. Oral Implants Res."},{"key":"49647_CR29","doi-asserted-by":"publisher","first-page":"116184","DOI":"10.1016\/j.bone.2021.116184","volume":"153","author":"JI Aguirre","year":"2021","unstructured":"Aguirre, J. I., Castillo, E. J. & Kimmel, D. B. Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone 153, 116184 (2021).","journal-title":"Bone"},{"key":"49647_CR30","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1902\/jop.2016.160273","volume":"88","author":"T Koutouzis","year":"2017","unstructured":"Koutouzis, T., Eastman, C., Chukkapalli, S., Larjava, H. & Kesavalu, L. A novel rat model of polymicrobial peri-implantitis: A preliminary study. J. Periodontol. 88, e32\u2013e41 (2017).","journal-title":"J. Periodontol."},{"key":"49647_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/clr.12777","volume":"28","author":"Y Takamori","year":"2017","unstructured":"Takamori, Y. et al. Histopathological comparison of the onset of peri-implantitis and periodontitis in rats. Clin. Oral Implants Res. 28, 163\u2013170 (2017).","journal-title":"Clin. Oral Implants Res."},{"key":"49647_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1563\/aaid-joi-D-17-00157","volume":"43","author":"RL Wong","year":"2017","unstructured":"Wong, R. L. et al. Comparing the healing potential of late-stage periodontitis and peri-implantitis. J. Oral Implantol. 43, 437\u2013445 (2017).","journal-title":"J. Oral Implantol."},{"key":"49647_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40729-019-0203-5","volume":"6","author":"G Yue","year":"2020","unstructured":"Yue, G. et al. Is maxillary diastema an appropriate site for implantation in rats?. Int. J. Implant Dent. 6, 8 (2020).","journal-title":"Int. J. Implant Dent."},{"key":"49647_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/clr.13556","volume":"31","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Development of a peri-implantitis model in the rat. Clin. Oral Implants Res. 31, 203\u2013214 (2020).","journal-title":"Clin. Oral Implants Res."},{"key":"49647_CR35","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1111\/odi.13845","volume":"28","author":"Q He","year":"2021","unstructured":"He, Q. et al. Development of a rat model for type 2 diabetes mellitus peri-implantitis: A preliminary study. Oral Dis. 28, 1936\u20131946 (2021).","journal-title":"Oral Dis."},{"key":"49647_CR36","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/jre.12492","volume":"53","author":"X Yu","year":"2018","unstructured":"Yu, X. et al. Role of toll-like receptor 2 in inflammation and alveolar bone loss in experimental peri-implantitis versus periodontitis. J. Periodontal Res. 53, 98\u2013106 (2018).","journal-title":"J. Periodontal Res."},{"key":"49647_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/clr.13727","volume":"32","author":"Y Hori","year":"2021","unstructured":"Hori, Y. et al. Xerostomia aggravates ligation-induced peri-implantitis: A preclinical in vivo study. Clin. Oral Implants Res. 32, 581\u2013589 (2021).","journal-title":"Clin. Oral Implants Res."},{"key":"49647_CR38","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","volume":"20","author":"AA Khan","year":"2017","unstructured":"Khan, A. A. et al. International task force on osteonecrosis of the jaw. Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ. J. Clin. Densitom 20, 8\u201324 (2017).","journal-title":"J. Clin. Densitom"},{"key":"49647_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K McGowan","year":"2018","unstructured":"McGowan, K., McGowan, T. & Ivanovski, S. Risk factors for medication-related osteonecrosis of the jaws: A systematic review. Oral Dis. 24, 527\u2013536 (2018).","journal-title":"Oral Dis."},{"key":"49647_CR40","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jpor.2018.12.002","volume":"63","author":"T Mameno","year":"2019","unstructured":"Mameno, T. et al. Longitudinal study on risk indicators for peri-implantitis using survival-time analysis. J. Prosthodontic Res. 63, 216\u2013220 (2019).","journal-title":"J. Prosthodontic Res."},{"key":"49647_CR41","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","volume":"49","author":"MJ Rogers","year":"2011","unstructured":"Rogers, M. J., Crockett, J. C., Coxon, F. P. & M\u00f6nkk\u00f6nen, J. Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49, 34\u201341 (2011).","journal-title":"Bone"},{"key":"49647_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/odi.12513","volume":"22","author":"PG de Barros Silva","year":"2016","unstructured":"de Barros Silva, P. G. et al. Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw. Oral Dis. 22, 649\u2013657 (2016).","journal-title":"Oral Dis."},{"key":"49647_CR43","doi-asserted-by":"publisher","first-page":"46322","DOI":"10.1038\/srep46322","volume":"7","author":"M Morita","year":"2017","unstructured":"Morita, M. et al. Elevation of pro-inflammatory cytokine levels following anti-resorptive drug treatment is required for osteonecrosis development in infectious osteomyelitis. Sci. Rep. 7, 46322 (2017).","journal-title":"Sci. Rep."},{"key":"49647_CR44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1248\/bpb.b18-00923","volume":"42","author":"H Funayama","year":"2019","unstructured":"Funayama, H. et al. Effects of zoledronate on local and systemic production of IL-1\u03b2, IL-18, and TNF-\u03b1 in mice and augmentation by lipopolysaccharide. Biol. Pharm. Bull. 42, 929\u2013936 (2019).","journal-title":"Biol. Pharm. Bull."},{"key":"49647_CR45","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s00774-020-01174-2","volume":"39","author":"T Soma","year":"2021","unstructured":"Soma, T. et al. Tooth extraction in mice administered zoledronate increases inflammatory cytokine levels and promotes osteonecrosis of the jaw. J. Bone Miner. Metab. 39, 372\u2013384 (2021).","journal-title":"J. Bone Miner. Metab."},{"key":"49647_CR46","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1096\/fj.201801791RR","volume":"33","author":"W Zhu","year":"2019","unstructured":"Zhu, W. et al. Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw. FASEB J. 33, 5208\u20135219 (2019).","journal-title":"FASEB J."},{"key":"49647_CR47","doi-asserted-by":"publisher","first-page":"606043","DOI":"10.3389\/fimmu.2021.606043","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang, W. et al. The role of the immune response in the development of medication-related osteonecrosis of the jaw. Front. Immunol. 12, 606043 (2021).","journal-title":"Front. Immunol."},{"key":"49647_CR48","doi-asserted-by":"publisher","first-page":"116168","DOI":"10.1016\/j.bone.2021.116168","volume":"153","author":"JI Aguirre","year":"2021","unstructured":"Aguirre, J. I., Castillo, E. J. & Kimmel, D. B. Biologic and pathologic aspects of osteocytes in the setting of medication-related osteonecrosis of the jaw (MRONJ). Bone 153, 116168 (2021).","journal-title":"Bone"},{"key":"49647_CR49","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/mmr.2015.4627","volume":"13","author":"X Huang","year":"2016","unstructured":"Huang, X. et al. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Mol. Med. Rep. 13, 613\u2013622 (2016).","journal-title":"Mol. Med. Rep."},{"key":"49647_CR50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000351194","volume":"59","author":"FG Basso","year":"2013","unstructured":"Basso, F. G., Silveira Turrioni, A. P., Hebling, J. & de Souza Costa, C. A. Zoledronic acid inhibits human osteoblast activities. Gerontology 59, 534\u2013541 (2013).","journal-title":"Gerontology"},{"key":"49647_CR51","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.bjoms.2016.05.030","volume":"54","author":"M Lang","year":"2016","unstructured":"Lang, M. et al. Influence of zoledronic acid on proliferation, migration, and apoptosis of vascular endotelial cells. Br. J. Oral Maxillofac. Surg. 54, 889\u2013893 (2016).","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"49647_CR52","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s00784-012-0800-7","volume":"17","author":"M Mozzati","year":"2013","unstructured":"Mozzati, M. et al. Oral mucosa produces cytokines and factors influencing osteoclast activity and endothelial cell proliferation, in patients with osteonecrosis of jaw after treatment with zoledronic acid. Clin. Oral Investig. 17, 1259\u20131266 (2013).","journal-title":"Clin. Oral Investig."},{"key":"49647_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00784-009-0365-2","volume":"15","author":"T Ziebart","year":"2011","unstructured":"Ziebart, T. et al. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: Inhibition of cell function of endothelial progenitor cells and mature endotelial cells in vitro. Clin. Oral Investig. 15, 105\u2013111 (2011).","journal-title":"Clin. Oral Investig."},{"key":"49647_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41598-018-37063-y","volume":"9","author":"LF Toro","year":"2019","unstructured":"Toro, L. F. et al. Application of autologous platelet-rich plasma on tooth extraction site prevents occurence of medication-related osteonecrosis of the jaws in rats. Sci. Rep. 9, 22 (2019).","journal-title":"Sci. Rep."},{"key":"49647_CR55","first-page":"2893","volume":"9","author":"D Santini","year":"2003","unstructured":"Santini, D. et al. Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients. Clin. Cancer Res. 9, 2893\u20132897 (2003).","journal-title":"Clin. Cancer Res."},{"key":"49647_CR56","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00784-016-1718-2","volume":"20","author":"JW Kim","year":"2016","unstructured":"Kim, J. W. et al. Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw. Clin. Oral Investig. 20, 2251\u20132258 (2016).","journal-title":"Clin. Oral Investig."},{"key":"49647_CR57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00784-009-0300-6","volume":"14","author":"S Hoefert","year":"2010","unstructured":"Hoefert, S., Schmitz, I., Tannapfel, A. & Eufinger, H. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: A possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings. Clin. Oral Investig. 14, 271\u2013284 (2010).","journal-title":"Clin. Oral Investig."},{"key":"49647_CR58","doi-asserted-by":"publisher","first-page":"31604","DOI":"10.1038\/srep31604","volume":"6","author":"G Russmueller","year":"2016","unstructured":"Russmueller, G. et al. The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection. Sci. Rep. 6, 31604 (2016).","journal-title":"Sci. Rep."},{"key":"49647_CR59","doi-asserted-by":"publisher","first-page":"3406","DOI":"10.1038\/s41598-022-07375-1","volume":"12","author":"A Brody","year":"2022","unstructured":"Brody, A., Scheich, B. & Dobo-Nagy, C. Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws. Sci. Rep. 12, 3406 (2022).","journal-title":"Sci. Rep."},{"key":"49647_CR60","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.oooo.2016.11.011","volume":"123","author":"F Hallmer","year":"2017","unstructured":"Hallmer, F. et al. Bacterial diversity in medication-related osteonecrosis of the jaw. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 123, 436\u2013444 (2017).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"49647_CR61","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s00784-018-2655-z","volume":"23","author":"M Zirk","year":"2019","unstructured":"Zirk, M. et al. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw. Clin. Oral Investig. 23, 2143\u20132151 (2019).","journal-title":"Clin. Oral Investig."},{"key":"49647_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1615\/JLongTermEffMedImplants.2022044320","volume":"33","author":"A Rajasekar","year":"2023","unstructured":"Rajasekar, A. & Varghese, S. S. Bacterial profile associated with peri-implantitis: A systematic review. J. Long Term Eff. Med. Implants 33, 9\u201320 (2023).","journal-title":"J. Long Term Eff. Med. Implants"},{"key":"49647_CR63","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1902\/jop.2016.160184","volume":"87","author":"PJ P\u00e9rez-Chaparro","year":"2016","unstructured":"P\u00e9rez-Chaparro, P. J. et al. The current weight of evidence of the microbiologic profile associated with peri-implantitis: A systematic review. J. Periodontol. 87, 1295\u20131304 (2016).","journal-title":"J. Periodontol."},{"key":"49647_CR64","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1902\/jop.2017.170123","volume":"88","author":"GI Lafaurie","year":"2017","unstructured":"Lafaurie, G. I. et al. Microbiome and microbial biofilm profiles of peri-implantitis: A systematic review. J. Periodontol. 88, 1066\u20131089 (2017).","journal-title":"J. Periodontol."},{"key":"49647_CR65","doi-asserted-by":"publisher","first-page":"886411","DOI":"10.3389\/fcimb.2022.886411","volume":"12","author":"S Wu","year":"2022","unstructured":"Wu, S. et al. Porphyromonas gingivalis induces bisphosphonate-related osteonecrosis of the femur in mice. Front. Cell Infect. Microbiol. 12, 886411 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"49647_CR66","doi-asserted-by":"crossref","first-page":"6713","DOI":"10.1007\/s00520-021-06275-w","volume":"29","author":"S de Cassia Tornier","year":"2021","unstructured":"de Cassia Tornier, S., Macedo, F. J., Sassi, L. M. & Schussel, J. L. Quality\u00a0of\u00a0life\u00a0in cancer\u00a0patients\u00a0with or without medication-related\u00a0osteonecrosis\u00a0of the\u00a0jaw. Support. Care Cancer 29, 6713\u20136719 (2021).","journal-title":"Support. Care Cancer"},{"key":"49647_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/biomedicines8040095","volume":"8","author":"G Tenore","year":"2020","unstructured":"Tenore, G. et al. does medication-related osteonecrosis of the jaw influence the quality of life of cancer patients?. Biomedicines 8, 95 (2020).","journal-title":"Biomedicines"},{"key":"49647_CR68","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.archoralbio.2015.05.015","volume":"60","author":"PG Silva","year":"2015","unstructured":"Silva, P. G. et al. Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis. Arch. Oral Biol. 60, 1237\u20131245 (2015).","journal-title":"Arch. Oral Biol."},{"key":"49647_CR69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bone.2018.10.014","volume":"120","author":"E Ervolino","year":"2019","unstructured":"Ervolino, E. et al. Antimicrobial photodynamic therapy improves the alveolar repair process and prevents the occurrence of osteonecrosis of the jaws after tooth extraction in senile rats treated with zoledronate. Bone 120, 101\u2013113 (2019).","journal-title":"Bone"},{"key":"49647_CR70","doi-asserted-by":"publisher","first-page":"103172","DOI":"10.1016\/j.pdpdt.2022.103172","volume":"40","author":"E Ervolino","year":"2022","unstructured":"Ervolino, E. et al. Effectiveness of antimicrobial photodynamic therapy mediated by butyl toluidine blue in preventing medication-related osteonecrosis of the jaws in rats. Photodiagn. Photodyn. Ther. 40, 103172 (2022).","journal-title":"Photodiagn. Photodyn. Ther."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49647-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T14:09:12Z","timestamp":1730988552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-49647-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["49647"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-49647-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"30 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"627"}}